EUVIMEDEUVIMED entdecken
Open Access

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy

Daniel Hughes iD, Alice Evans, Simei Go iD, Michael Eyres, Liuliu Pan, Somnath Mukherjee, Zahir Soonawalla iD, Frances Willenbrock iD, Eric O'Neill iD

Science Advances · 05.07.2024 · 10 (27)

DOI: 10.1126/sciadv.adm9071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.07.2024. Verfasst von Daniel Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Precision Medicine, Tumor Microenvironment. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, a disease with dismal overall survival. Advances in treatment are hindered by a lack of preclinical models. Here, we show how a personalized organotypic “avatar” created from resected tissue allows spatial and temporal reporting on a complete in situ tumor microenvironment and mirrors clinical responses. Our perfusion culture method extends tumor slice viability, maintaining stable tumor content, metabolism, stromal composition, and immune cell populations for 12 days. Using multiplexed immunofluorescence and spatial transcriptomics, we identify immune neighborhoods and potential for immunotherapy. We used avatars to assess the impact of a preclinically validated metabolic therapy and show recovery of stromal and immune phenotypes and tumor redifferentiation. To determine clinical relevance, we monitored avatar response to gemcitabine treatment and identify a patient avatar-predictable response from clinical follow-up. Thus, avatars provide valuable information for syngeneic testing of therapeutics and a truly personalized therapeutic assessment platform for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsPrecision MedicineTumor MicroenvironmentAnimalsHumansCell Line, TumorDeoxycytidineGemcitabineImmunotherapy

Substanzen

DeoxycytidineGemcitabine

Autor:innen und Institutionen

  • Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
  • Medicines Discovery Catapult, Alderley Park SK10 4ZF, UK.
  • NanoString Technologies Inc., Seattle, WA, USA.
  • Department of HPB surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7DQ, UK.

ORCID-Profile: Daniel Hughes, Simei Go, Zahir Soonawalla, Frances Willenbrock, Eric O'Neill

Zitieren

APA

Hughes, D., Evans, A., Go, S., Eyres, M., Pan, L., Mukherjee, S., Soonawalla, Z., Willenbrock, F., & O'Neill, E. (2024). Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy. Science Advances, 10(27). https://doi.org/10.1126/sciadv.adm9071

Vancouver

Hughes D, Evans A, Go S, Eyres M, Pan L, Mukherjee S, et al. Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy. Science Advances. 2024;10(27). doi:10.1126/sciadv.adm9071

BibTeX
@article{Hughes2024,
  author = {Hughes, Daniel and Evans, Alice and Go, Simei and Eyres, Michael and Pan, Liuliu and Mukherjee, Somnath and Soonawalla, Zahir and Willenbrock, Frances and O'Neill, Eric},
  title = {Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {27},
  doi = {10.1126/sciadv.adm9071}
}
Kostenlos starten →